Company intelligence / Profile preview

Berlex Laboratories

Montville, New Jersey, USAencyclopedia.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Prior to its integration into Bayer HealthCare Pharmaceuticals in April 2007, Berlex had commercialized several specialty pharmaceuticals and biologics—most notably Leukine—and was conducting late-stage clinical trials for expanded indications such as Crohn's disease. The company also focused on women’s health and diagnostic imaging products.[3][4][5]

Therapeutic areas: HematologyOtherRheumatologyGastroenterologyWomen's Health
Modalities: Small moleculesBiologics/protein-based therapeutics[4][5]
Industry: Pharma

Drug pipeline

3 assets

betaseron

Commercial

Indications: Multiple sclerosis

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Berlex Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Berlex Laboratories.

Explore the full profile